Apixaban

Apixaban in Thrombocytopenia

A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

Comparing the Safety and Efficacy of Apixaban and Rivaroxaban

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis

Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers

Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia

SWITCH: Apixaban vs Vitamin K in HM3

Anticoagulation in Patients With Venous Thromboembolism and Cancer

High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France

Apixaban Safety and Therapy Adherence in Patients With Atrial Fibrillation

A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects

Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

A Study to Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Low-Dose Apixaban Added to Standard Heparin Lock Versus Heparin Lock Alone to Prevent Tunneled Hemodialysis Catheters Dysfunction (APICATH-HD)

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery

Venous Thromboembolism Prevention in Outpatients With Glioma

Comparison of Apixaban Versus Enoxaparin